Introduction

The treatment of lung cancer has changed dramatically over the past decade. Instead of relying solely on chemotherapy, many patients with non-small cell lung cancer (NSCLC) can now benefit from targeted therapies that are designed to attack specific genetic mutations within cancer cells.

While these medicines have improved survival and quality of life for many patients, one question remains common among patients and caregivers:

“How much does targeted therapy for lung cancer cost in India?”

The answer depends on several factors, including the type of medicine prescribed, treatment duration, genetic mutations, and whether patients have access to generic alternatives or patient assistance pathways.

At Curiance Biotech, we believe patients should understand not only their treatment options but also the factors that influence treatment affordability.

What Is Targeted Therapy?

Targeted therapy is a type of cancer treatment that attacks specific molecular changes responsible for cancer growth.

Unlike chemotherapy, which affects rapidly dividing cells throughout the body, targeted therapies focus on cancer cells carrying particular genetic mutations.

Some of the most common lung cancer biomarkers include:

• EGFR mutation
• ALK rearrangement
• ROS1 fusion
• BRAF mutation
• MET exon 14 skipping
• RET fusion
• KRAS G12C mutation

Identifying these mutations requires molecular testing before treatment begins.

Why Does Cost Vary?

There is no single price for targeted therapy because treatment depends on the patient’s individual diagnosis.

Factors affecting cost include:

1. Type of Medicine

Different targeted therapies have different pricing structures depending on manufacturing, regulatory approvals, and market availability.

2. Brand vs Generic Medicine

Where high-quality generic versions are available and appropriate, treatment costs may be lower than branded products.

Patients should always discuss medicine selection with their treating oncologist.

3. Treatment Duration

Many targeted therapies are taken daily for months or years while the disease remains under control.

The overall treatment cost depends on the length of therapy.

4. Diagnostic Testing

Before prescribing targeted therapy, oncologists generally recommend molecular testing to identify actionable genetic mutations.

Testing itself contributes to the overall treatment journey.

5. Monitoring and Follow-Up

Patients usually require:

• Blood tests
• CT scans
• MRI scans (when appropriate)
• Clinical follow-up visits

These investigations are essential for monitoring treatment effectiveness.

Common Targeted Therapies Used in India

Depending on the patient’s mutation profile, targeted therapies may include:

• Osimertinib (EGFR mutation)
• Erlotinib
• Gefitinib
• Alectinib
• Lorlatinib
• Crizotinib
• Brigatinib
• Tepotinib
• Selpercatinib

The appropriate medicine depends entirely on molecular testing and the oncologist’s recommendation.

Why Genetic Testing Is Worth the Investment

Some patients hesitate because molecular testing adds an initial expense.

However, accurate testing helps:

• Identify the most effective treatment
• Avoid ineffective therapies
• Improve response rates
• Reduce unnecessary side effects

Precision medicine begins with identifying the correct mutation.

Can Generic Medicines Improve Affordability?

Yes.

High-quality generic oncology medicines have significantly improved access for many patients.

When manufactured according to internationally recognized quality standards, generic medicines can:

• Improve affordability
• Increase treatment access
• Reduce financial burden
• Support long-term treatment continuity

Patients should only obtain medicines from trusted, quality-assured suppliers.

Other Costs Patients Should Consider

Treatment involves more than medication alone.

Additional expenses may include:

• Hospital consultations
• Diagnostic imaging
• Laboratory tests
• Travel
• Accommodation (for patients traveling long distances)
• Supportive medicines
• Nutritional support

Planning ahead can help patients and families better manage these costs.

Does Insurance Cover Targeted Therapy?

Coverage varies depending on:

• Health insurance policy
• Employer benefits
• Government healthcare programs
• Individual treatment plans

Patients are encouraged to discuss reimbursement options with both their healthcare provider and insurance company.

Accessing Targeted Therapy Through Curiance Biotech

For patients prescribed Osimertinib or other oncology medicines, Curiance Biotech supports access through established regulatory pathways, including the Named Patient Medicine framework where applicable.

Our services include:

• Patient support
• International medicine access
• Regulatory documentation guidance
• Quality-assured sourcing
• Worldwide delivery support

We work alongside healthcare professionals to help eligible patients access prescribed medicines responsibly.

Frequently Asked Questions

Is targeted therapy more expensive than chemotherapy?

Targeted therapies often have different cost structures than chemotherapy. The total cost depends on the medicine prescribed, treatment duration, and individual clinical circumstances.

Does every lung cancer patient receive targeted therapy?

No.

Only patients whose tumors carry specific actionable genetic mutations are candidates.

Can generic medicines reduce treatment costs?

In many cases, quality-assured generic medicines improve affordability while expanding access to treatment.

Is molecular testing necessary?

Yes.

Targeted therapy should only be started after appropriate molecular testing confirms an eligible mutation.

Final Thoughts

Targeted therapy has transformed the treatment of lung cancer by allowing oncologists to match medicines to specific genetic mutations.

While treatment costs vary depending on several clinical and logistical factors, advances in precision medicine, high-quality generics, and patient access programs are helping improve affordability for many patients.

The most important first step remains molecular testing, followed by a personalized treatment plan developed by an experienced oncologist.

At Curiance Biotech, we are committed to improving awareness, education, and responsible access to quality oncology medicines for patients across India and around the world.

Medical Disclaimer

This article is intended for educational purposes only and should not replace professional medical advice. Patients should consult their oncologist regarding diagnosis, treatment selection, pricing, and medicine availability.